Dr. David Daniel Manevitz, D.O. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 70 Glen St, Suite380, Glen Cove, NY 11542 Phone: 516-759-2424 Fax: 516-759-6627 |
Neel Chandel, MD Physical Medicine & Rehabilitation - Spinal Cord Injury Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Saint Andrews Ln, Glen Cove, NY 11542 Phone: 516-674-7501 |
Ryszard Sapinski, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: Glen Cove Hospital-dept Of Pm&r, 101 St. Andrews Lane, Glen Cove, NY 11542 Phone: 516-674-7500 |
Dr. Vicki Lynn Seidenberg, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: Northshore University Hospital @ Glen Cove, 101 St. Andrews Lane, Glen Cove, NY 11542 Phone: 516-674-7500 Fax: 516-494-9755 |
Barry Root, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: Glen Cove Hospital Dept Of Pm And R, 101 St. Andrews Lane, Glen Cove, NY 11542 Phone: 516-674-7500 |
Craig H Rosenberg, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 70 Glen St, Ste 101, Glen Cove, NY 11542 Phone: 516-630-3525 Fax: 888-279-5444 |
Rawa Araim, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 101 Saint Andrews Ln, Glen Cove, NY 11542 Phone: 516-674-7300 |
News Archive
Patients treated at mobile health clinics report a high level of engagement in their care and the motivation to pursue healthy behaviors, according to the results of a qualitative study led by Zoe Bouchelle, Harvard Medical School Class of 2017, and communications scholar Heather Carmack of James Madison University.
General practitioners trained in compression ultrasonography have excellent accuracy and agreement in diagnosing symptomatic proximal deep vein thrombosis.
Leading Republicans readying for a White House run in 2016 also unofficially kicked off their campaigns in New Hampshire Saturday by hammering the health law.
Johnson & Johnson revealed Tuesday this week that a clinical trial of its experimental pain drug, fulranumab, has been stopped after the Food and Drug Administration expressed concerns that patients taking the drug could suffer increased joint damage.
› Verified 8 days ago